Molina Healthcare sets October 21 results. Molina Healthcare stock sits 22.78 percent below its high

Published on 10/01/2026 at 09:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue was USD 10.87 billion, down 4.80 percent year over year. Molina Healthcare stock costs EUR 166.95 on October 1, 2026 after EUR 166.90.

Moderner Klinikcampus mit Glasfassade und Gesundheitspersonal vor Skyline — Fotorealistisches Bild zeigt Molina Healthcare US60855R1005 als modernen Klinikcampus mit Personal und Skyline im Hintergrund, Illustration mit AI erstellt.

Molina Healthcare (ISIN US60855R1005) was trading at EUR 166.95 at Lang & Schwarz on October 1, 2026 at 9:04 a.m. CEST, plus 0.03 percent versus the prior close of EUR 166.90. The company set October 21, 2026 for its third-quarter earnings release in an announcement dated September 2, 2026, as Marketscreener reported. The primary-market quote was USD 189.10 on September 30, 2026, leaving the stock 22.78 percent below its USD 244.89 52-week high.

Results date sets the next checkpoint

The October 21 release covers the third quarter ending September 30, 2026, while the conference call is scheduled for October 22, 2026. That calendar date gives the stock a defined near-term information point after a volatile earnings cycle.

The second-quarter comparison explains why the next report matters. MarketBeat reported USD 10.87 billion in second-quarter 2026 revenue, down 4.80 percent year over year, while earnings per share reached USD 1.51 against a USD 1.39 consensus estimate. The USD 0.12 earnings-per-share gap was positive, but the revenue decline keeps operating performance central to the October release.

Analyst view stays divided

MarketBeat said Zacks Research upgraded Molina Healthcare from hold to strong buy on September 24, 2026. The broader analyst consensus remained hold, with an average price target of USD 202.44, while the published range ran from USD 147.00 to USD 266.00.

The market-capitalization context is more restrained than the highest target. Molina Healthcare was valued at USD 9.9 billion as of September 30, 2026, and the USD 189.10 primary-market quote stood below the USD 202.44 average target by 6.60 percent. The comparison leaves the October earnings release as the next concrete test for revenue and profitability.

EUR 166.95 in early trading

Molina Healthcare was trading at EUR 166.95 at Lang & Schwarz on October 1, 2026 at 9:04 a.m. CEST, plus 0.03 percent versus the prior close of EUR 166.90 on September 30, 2026. The further course of trading is shown by the continuously updated real-time quote of Molina Healthcare stock.